SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Tarsus Pharmaceuticals Q3 Loss Widens as Revenue Rises

Tarsus Pharmaceuticals reported a wider net loss and higher revenue in Q3.

TARS

Related stories